StonvexLoading…
StonvexStonvexStonvexCore line items from GENC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $23.58M | $115.44M | $96.61M | $69.62M |
Operating Income | $3.10M | $14.02M | $14.24M | $11.10M |
Net Income | $3.44M | $15.66M | $13.74M | $6.09M |
EPS (Diluted) | $0.23 | $1.07 | $0.94 | $0.68 |
Total Assets | $228.91M | $222.60M | $220.16M | $223.93M |
Total Liabilities | $13.67M | $10.79M | $10.28M | $17.87M |
Cash & Equivalents | $36.73M | $26.59M | $27.87M | $52.27M |
Free Cash Flow OCF − CapEx | $10.14M | $1.10M | $2.39M | $26.79M |
Shares Outstanding | 14.66M | Not available | 14.66M | 14.66M |